NeurosciencebioRxivPreprint
A new therapeutic approach for Parkinson's disease: dual targeting of alpha-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide
Maria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola…·Anna Rosa Carta
This paper evaluates 3MP, a novel immunomodulator, showing it reduces alpha-Synuclein aggregation and microglial inflammation in vitro and in vivo, offering a dual-target therapeutic approach for Parkinson's disease.
DOI 10.64898/2026.03.26.714051